[Covid19freak]

2x Phase 3 drugs and an Alzheimer drug in Phase 2 and company is valued at ridiculous 13 million valuation

[Covid19freak]

NEUP - MC 13m ,Phase 3 data in Q3 for SAD trial and has Alzheimer drug in Phase 2 partnered with pharma giant Merck .this under radar Company has only 1.88 million outstanding shares if we get positive phase 3 data next quarter this going to explode hard .

June slide presentation
https://ir.neuphoriatx.com/static-files/16597ddb-df56-48a4-9e01-a2f3c099c3fd


AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025

a7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s

Cash runway into Q3 2026

[glenn1919]

NEUP......................................anotherwwwwwwwwwwwwwwwwwwwwwwwwwwweeeeeeeeeeeeeeeeeeeeeeeeeeeeee

[tw0122]

Did I forget something maybe memory loss $6.50 + 80% 
Now 

[glenn1919]

neup.....................bounce...................................https://stockcharts.com/h-sc/ui?s=neup&p=W&b=5&g=0&id=p86431144783

[tw0122]

NEUP Alzheimer's Merck $5.33

[glenn1919]

NEUP...........................https://stockcharts.com/h-sc/ui?s=NEUP&p=W&b=5&g=0&id=p86431144783